Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Argent Biopharma ( (AU:RGT) ) has shared an announcement.
Argent Biopharma Limited has announced the quotation of 6,250,000 ordinary fully paid securities on the Australian Securities Exchange (ASX) as of April 23, 2025. This move is part of previously announced transactions and is expected to enhance the company’s market presence and liquidity, potentially impacting its operations and stakeholder interests positively.
More about Argent Biopharma
Argent Biopharma Limited operates in the biopharmaceutical industry, focusing on the development and commercialization of innovative medical therapies. The company is known for its commitment to advancing healthcare solutions and holds a significant position in the market for its pioneering products.
YTD Price Performance: -20.83%
Average Trading Volume: 554
Technical Sentiment Signal: Buy
Current Market Cap: $6.65M
Find detailed analytics on RGT stock on TipRanks’ Stock Analysis page.